Wits’ new Vice-Chancellor Zeblon Vilakazi, born in Katlehong, Ekurhuleni, and one of the first Africans to work at Cern in Geneva, admitted that the university made mistakes with #FeesMustFall, and shares his dream of making it a hotbed for innovation, while changing the curriculum within two years. Witwatersrand University's newly appointed vice-chancellor Zeblon Vilakazi has grand…
Comedian Rob Van Vuuren speaks about how Black Lives Matter, how his daughter inspired him to apologise, how and why white South Africa reacted so negatively to his apology, and the trauma he experienced that shaped his views. Acclaimed South African comedian Rob Van Vuuren says his apology last week Sunday for using blackface in a…
Bishop Malusi Mpumlwana believes there has been "no compliance" with the Covid-19 lockdown hygiene regulations, that the country's economy is at the same place it was near the end of apartheid, and that white South Africans have to do more to bring about reconciliation. The new chairperson of the ministerial advisory committee on social behavioural change,…
Former Johannesburg mayor Herman Mashaba believes the DA has deserted the values of non-racialism in South Africa, and that the ANC went into exile to loot the country.Herman Mashaba believes DA federal chairperson Helen Zille would be complicit if the allegations she made against him are true.Zille, who's return to politics last year sparked Mashaba's…
Government communications head Phumla Williams says the emotional "torture" she endured as acting GCIS director-general under former communications minister Faith Muthambi was similar to apartheid abuse, adding young people will have to start creating their own opportunities. After eight years as the acting director-general of the Government Communication Information System (GCIS), Phumla Williams says she is relieved the Cabinet has finally appointed her permanently…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f